Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bluejay Diagnostics, Inc. (BJDX : NSDQ)

• Company Description    Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $1.57 Daily Weekly Monthly 20 Day Moving Average: 136,330 shares Shares Outstanding: 1.49 (millions) Market Capitalization: $2.35 (millions) Beta: 0.48 52 Week High: $8.25 52 Week Low: $1.26 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 19.85% 17.74% 12 Week -2.48% -11.42% Year To Date -67.76% -73.05%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MASSACHUSETTS AVENUE SUITE 203 - ACTON,MA 01720 USA ph: 844-327-7078 fax: - ir@bluejaydx.com https://bluejaydx.com

• General Corporate Information    Officers Neil Dey - Chief ExecutiveOfficer Douglas C. Wurth - Chairman Donald R. Chase - Director Fred S. Zeidman - Director Gary Gemignani - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 095633509 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 1.49 Most Recent Split Date: 11.00 (0.02:1) Beta: 0.48 Market Capitalization: $2.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.44 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 99.45% vs. Previous Quarter: 58.16% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - -362.07 03/31/25 - -322.46 12/31/24 - -336.37 ROA 06/30/25 - -299.10 03/31/25 - -262.96 12/31/24 - -270.68 Current Ratio 06/30/25 - 4.56 03/31/25 - 2.71 12/31/24 - 6.05 Quick Ratio 06/30/25 - 4.56 03/31/25 - 2.71 12/31/24 - 6.05 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - 3.54 03/31/25 - 6.98 12/31/24 - 10.34 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©